Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Washington University School of Medicine

St Louis

MO 63130

USA

Name/email consistency: high

Washington University School of Medicine, St Louis, MO 63130, USA. 2003
Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, USA. 2001 - 2002
Alvin J. Siteman Cancer Center, St. Louis, Missouri, USA. 2002

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study. Fracasso, P.M., Blessing, J.A., Wolf, J., Rocereto, T.F., Berek, J.S., Waggoner, S. Gynecol. Oncol. (2003) [Pubmed]
Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study. Fracasso, P.M., Blessing, J.A., Morgan, M.A., Sood, A.K., Hoffman, J.S. J. Clin. Oncol. (2003) [Pubmed]
Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies. Fracasso, P.M., Blum, K.A., Tan, B.R., Fears, C.L., Bartlett, N.L., Arquette, M.A., Clark, R.S. Cancer (2002) [Pubmed]
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. Fracasso, P.M., Rader, J.S., Govindan, R., Herzog, T.J., Arquette, M.A., Denes, A., Mutch, D.G., Picus, J., Tan, B.R., Fears, C.L., Goodner, S.A., Sun, S.L. Ann. Oncol. (2002) [Pubmed]
Overcoming drug resistance in ovarian carcinoma. Fracasso, P.M. Curr. Oncol. Rep (2001) [Pubmed]
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study. Fracasso, P.M., Brady, M.F., Moore, D.H., Walker, J.L., Rose, P.G., Letvak, L., Grogan, T.M., McGuire, W.P. J. Clin. Oncol. (2001) [Pubmed]